Joseph Meserve

Joseph Meserve

University of California San Diego - San Diego / United States
Medical and Health Sciences / Gastroenterology
AD Scientific Index ID: 1876447
person_outline Joseph Meserve's MOST POPULAR ARTICLES
1-) Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium (vol 113, pg 1345, 2018)N Narula, F Peerani, J Meserve, G Kochhar, K Chaudrey, J Hartke, ...AMERICAN JOURNAL OF GASTROENTEROLOGY 113 (12), 1912-1912, 2018107*2018
2-) Vedolizumab for ulcerative colitis: treatment outcomes from the VICTORY consortiumN Narula, F Peerani, J Meserve, G Kochhar, K Chaudrey, J Hartke, ...The American journal of gastroenterology 113 (9), 1345, 20181062018
3-) Development and validation of a scoring system to predict outcomes of vedolizumab treatment in patients with Crohn’s diseasePS Dulai, BS Boland, S Singh, K Chaudrey, JL Koliani-Pace, G Kochhar, ...Gastroenterology 155 (3), 687-695. e10, 2018932018
4-) Retrospective analysis of safety of vedolizumab in patients with inflammatory bowel diseasesJ Meserve, S Aniwan, JL Koliani-Pace, P Shashi, A Weiss, D Faleck, ...Clinical Gastroenterology and Hepatology 17 (8), 1533-1540. e2, 2019902019
5-) Development and validation of clinical scoring tool to predict outcomes of treatment with vedolizumab in patients with ulcerative colitisPS Dulai, S Singh, NV Casteele, J Meserve, A Winters, S Chablaney, ...Clinical Gastroenterology and Hepatology 18 (13), 2952-2961. e8, 2020712020